Direxion Daily S&P Biotech Bear 3X Shares
LABD
LABD
12 hedge funds and large institutions have $23.7M invested in Direxion Daily S&P Biotech Bear 3X Shares in 2018 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
9% more funds holding
Funds holding: 11 → 12 (+1)
1.14% more ownership
Funds ownership: 0.14% → 1.27% (+1.1%)
Holders
12
Holding in Top 10
–
Calls
$34.7M
Puts
$4.07M
Top Buyers
| 1 | +$5.48M | |
| 2 | +$2.09M | |
| 3 | +$1.26M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$304K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$210K |
Top Sellers
| 1 | -$492K | |
| 2 | -$208K | |
| 3 | -$65.8K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$15K |
| 5 |
CG
Cutler Group
San Francisco,
California
|
-$933 |